期刊文献+

转化生长因子β和Smad4在子宫内膜病变中的表达 被引量:1

Expression of transforming growth factor-beta and Smad4 in endometrial lesion
原文传递
导出
摘要 目的检测转化生长因子β(TGF-β1)和Smad4在子宫内膜病变中表达情况,探讨其与子宫内膜癌变发生的关系。方法免疫组化(SP)法检测在正常增殖期子宫内膜(NE,n=30)、复杂增生子宫内膜(CH,n=31)、不典型增生子宫内膜(AH,n=45)及子宫内膜腺癌(EC,n=41)中转化生长因子β和Smad4的表达情况。结果转化生长因子β在NE组到EC组的表达呈升高趋势,差异有统计学意义(P<0.05);同时其在腺癌组织中的表达与肿瘤肌层浸润深度及分化程度呈正相关(P<0.05)。而Smad4在EC组中阳性表达率明显低于NE组,差异亦具统计学意义(P<0.05);其与腺癌肌层浸润呈正相关(P<0.05)。结论转化生长因子β及Smad4与子宫内膜腺癌发生、演进密切相关。 Objective To detect the expression of transforming growth factor-beta ( TGF-β1 ) and Smad4 in endometrial lesions, and to explore the relationship between TGF-β1 and Smad4 with the occurrence of endometrial adenocarcinoma (EC). Methods To investigate the expressions of TGF-β1 and Smad4 using immunohistochemistry in normal proliferative endometrium (NE , n = 30), complex hyperplasia (CH ,n = 31 ), atypical hyperplasia (AH ,n =45), and endometrial adenocarcinoma (EC,n = 41 ). Results The expression of TGF-β1 was significantly higher in EC than that in NE, (P 〈0.05 ). Expression of TGF-β1 was significantly correlated with tumor grade and myometrial invasion of EC (P 〈 0. 05). And the expression level of Smad4 was significantly lower in EC than that in NE (P 〈 0.05 ). Expression of Smad4 was significantly correlated with myometrial invasion of endometrial carcinoma( P 〈 0.05 ). Conclusions TGF-β1 and Smad4 may be closely associated with tumor genesis and pathobiological behaviors of endometrial adenocarcinoma.
作者 范春明
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第6期462-464,共3页 Chinese Journal of Practical Gynecology and Obstetrics
基金 辽宁省教育厅高校科研基金项目(2008812)
关键词 转化生长因子Β SMAD4 子宫内膜病变 免疫组织化学 transforming growth factor-beta Smad4 endometrial lesion immunohistochemistry
  • 相关文献

参考文献11

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2Maurice D, Pierreux CE, Howell M, et al. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability[J]. J Bilo Chem, 2001, 276(46): 43175- 43181.
  • 3Li Q, Haang W, Zhou X. Expression of CD34, alpha-smooth muscle actin and transforming growth faetor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix [J]. J Int Med Res, 2009,37(2) :446-54.
  • 4Sulkowski S, Wincewicz A, Sulkowska M, et al. Transforming growth factor-betal and regulators of apoptosis [ J]. Ann N Y Acad Sci, 2009,1171 (8) :116-123.
  • 5Narkiewicz J, Lapinska-Szumczyk S, Zurawa-Janicka D, et al. Expression of human HtrA1, HtrA2, HtrA3 and TGF-betal genes in primary endometrial cancer[J]. Oncol Rep, 2009,21 (6) : 1529- 1537.
  • 6Liu FS, Chen JT, Hsieh YT, et al. Loss of smad4 protein expression occurs infrequenlly in endometrial carcinomas[ J ]. Int J Gynecol Pathl,2003,22(4) :347-352.
  • 7Muraoka RS, Dumont N, Ritler CA, et al. Blockade of TGFβ1 inhibits mammary tumor cell viability, migration and metastases[ J ]. J Clin Invest, 2002,109 ( 12 ) : 1551-1559.
  • 8de la Cruz-Merino L, Henao-Carrasco F, Garcia-Manrique T,et al. Role of transforming growth factor beta in cancer microenvironment [ J]. Clin Transl Oncol, 2009,11 ( 11 ) :715-720.
  • 9Teicher BA. Malignant cells, directors of the malignant process: role of transforming growth factor-beta [ J ]. Cancer Metastasis Rev,2001,20(1-2) :133-143.
  • 10Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, et al. Expression and intracellular localization of smad proteins in human endometrial cancer[ J ]. Oncol Rep,2003,10 ( 5 ) : 1539- 1544.

二级参考文献3

共引文献1367

同被引文献21

  • 1李怀芳,陈信良,李莉,沈爱群,刘彧,欧阳一芹.老年宫颈癌患者癌组织中转化生长因子β_1和P53的表达[J].中华老年医学杂志,2006,25(6):453-454. 被引量:4
  • 2de la Cruz-Merion L,Henao-Carrasco F,Garcfa-Manrique T,et al.Role of transforming growth factor beta in cancer microenvironment[J].Clin Transl Oncol,2009; 11(11):715 -720.
  • 3Schwarte-Waldhoff I,Volpert OV,Bouck NP,et al.Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis[J].Proc Natl Acad Sci USA,2000;97(17):9624 -9629.
  • 4Hazelbag S,Gorter A,Kenter GG,et al.Transforming growth factor-betal induces tumor stroma and reduces tumor infiltrate in cervical cancer[J].Hum Pathol,2002;33(12):1193 -1199.
  • 5Stenvers KL,Turskym L,Heart and liver defects and reduced transforming growth factor beta sensitivity in transforming growth factor beta type Ⅲ receptor deficient embryo[J].Mol Cell Biol,2003 ;23(12):4371 -4385.
  • 6Derynck R,Zhang YE.Smad-dependent and Smad-independent pathways in TGF-beta family signaling.Nature,2003 ;425:577-584.
  • 7Massague J.TGF beta in Cancer[J].Cell,2008;134:215-230.
  • 8Hahn SA,Schutte M,Hoque AT,Moskaluk CA,da Costa LT,Rozenblum E,Weinstein CL,Fischer A,Yeo CJ,Hruban RH,Kern SE.DPC4,a candidate tumor suppressor gene at hunman chromosome 18q21.1.Science 1996 ;271:350-353.
  • 9Tjiong MY,van der Vange N,ter Schegget JS,et al.Cytokines in cervicov-aginal washing fluid from patients with cervical neoplasia[J].Cytokine,2001; 14 (6):357-360.
  • 10Totng PL,Chan WY,Lin CT,et al.Decreased expression of human papillomavirus E2 protein and transforming growth factor-betal in human cervical neoplnsia as an early marker in carcinogenesis[J].J Surg Oncol,2003;84(1):17 -23.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部